Hagan et al v. Pd-Rx Pharmaceuticals Inc et al

Filing 195

ORDER granting 194 Motion to Dismiss. Signed by Honorable David L. Russell on 6/1/16. (jw)

IN THE UNITED STATES DISTRICT COURT FOR THE
WESTERN DISTRICT OF OKLAHOMA

LESLIE HAGAN, et al.,
Plaintiffs,
vs.
PD-RX PHARMACEUTICALS INC., et al.,
Defendants.

)
)
)
)
)
)
)
)
)
)

Civil Action No. 5:15-cv-00565-R

ORDER
Before the Court is the joint motion to dismiss the claims of all Plaintiffs against
Defendants Teva Pharmaceuticals USA, Inc.; Defendant Watson Pharmaceuticals, Inc.
n/k/a Actavis, Inc.; Defendants Neosan Pharmaceuticals, Inc., AAIPharma Development
Services, Inc., AAIPharama, Inc., and AAIPharma, LLC; Defendants Cornerstone
Biopharma, Inc., and Cornerstone Biopharma Holdings, LLC (formerly known as and
sued herein as Cornerstone Biopharma Holdings, Inc.); Defendants Mallinckrodt Inc. and
Covidien Inc.; and Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. Doc. No. 194.
Upon due consideration, the Court GRANTS the Motion. Plaintiffs’ claims against
these Defendants are DISMISSED WITH PREJUDICE.
IT IS SO ORDERED, this 1st day of June 2016.